Variation in organ‐specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas

Large‐scale sequencing efforts have described the mutational complexity of individual cancers and identified mutations prevalent in different cancers. As a complementary approach, allele‐specific competitive blocker PCR (ACB‐PCR) is being used to quantify levels of hotspot cancer driver mutations (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Barbara L., McKim, Karen L., Myers, Meagan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601221/
https://www.ncbi.nlm.nih.gov/pubmed/28755461
http://dx.doi.org/10.1002/em.22110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601221/
https://www.ncbi.nlm.nih.gov/pubmed/28755461
http://dx.doi.org/10.1002/em.22110

Ejemplares similares